Contact Us

Chintu Patel, CEO of Amneal Pharmaceuticals, to Speak at LIU Pharmacy’s Commencement Ceremony

Contact

University Center,
516-299-3298

Brooklyn, N.Y. (April 27, 2017) – Chintu Patel, CEO of Amneal Pharmaceuticals, a Long Island based pharmaceutical company ranking as the seven largest generic manufacturer in the United States, will be the featured keynote speaker at LIU’s Arnold and Marie Schwartz College of Pharmacy and Health Sciences commencement ceremony on May 7, 2017 at the Tilles Center for the Performing Arts on the LIU Post campus at 10 a.m.  The ceremony will also recognize LIU Pharmacy alum Ian Jay Ginsberg, Class of 1985, current President of C.O. Bigelow Apothecaries and Bigelow Trading, Ltd, with an honorary degree.

The graduating class of 2017 includes an estimated 104 PhD and Masters of Science students and 177 students set to graduate with Doctor of Pharmacy degrees. Since the very first graduating class of 1892, medals have been awarded to those students having achieved superior academic standing, with the three highest grade point averages. This year’s gold medal will go to Mitulkumar Patel, the silver medal to Daria Zavgorodnyaya, and the bronze to Debra Willner.

“The Class of 2017 has demonstrated a record level of excellence and has helped raise LIU Pharmacy to new heights,” said Kimberly R. Cline, President of LIU. “As industry leaders, Mr. Patel and Mr. Ginsberg highlight LIU Pharmacy’s reach into the heart of the pharmaceutical industry, and our shared commitment to quality, integrity and innovation.”

Chintu Patel has spent his career developing superior and affordable medicines to benefit people around the world through research and development.   He has more than 20 years of distinguished experience within the industry, starting his career in Eckerd Pharmacy. He has been recognized by his peers on numerous occasions, including the 2011 Ernst & Young National Entrepreneur of the Year Life Sciences Award.

His commitment to business growth and philanthropy is evident in the many organizations he supports. Patel has been a featured speaker at the Hauppauge Industrial Association of New York and serves on the boards of the Long Island Association and the Make-a-Wish Foundation. Along with his wife, Falguni, he created the Irada Foundation, focusing on health and education issues.

According to IMS Health, Amneal is the fastest-growing global generics company.  The company now has more than 4,000 employees with offices in Australia, Europe and Asia. As Amneal continues to experience unprecedented growth, its focus on quality, superb service levels, and building strong relationships holds firm and stands as testament to the strength of its reputation.

“LIU Pharmacy’s vision to advance the safety, efficacy and efficiency of the industry and the evolution of its professionals makes it a perfect fit for Mr. Patel, a leader in the pharmaceutical industry,” said Dr. John M. Pezzuto, dean of LIU Pharmacy. “We aim to work with leaders like Mr. Patel to create transformational opportunities for our students and faculty to do impactful all over the globe.”

LIU Pharmacy has recently expanded its partnerships with the pharmaceutical industry under Dr. Pezzuto, a past winner of the American Association of College’s of Pharmacy’s prestigious Volwiler Research Award, with impactful research in the University’s three state-of-the-art institutes: the Lachman Institute for Pharmaceutical Analysis, the Joan B. and Samuel J. Williamson Institute for Pharmacometrics, and the Natoli Engineering Institute for Industrial Pharmacy Development and Research. 

LIU Pharmacy was recently awarded a $2 million grant from the U.S. Food and Drug Administration (FDA), to be used in partnership with Purdue University School of Chemical Engineering, aiming to create a better understanding of the design and manufacturing control needed for new drug products.

It was also recently named as a member of the prestigious National Institute for Pharmaceutical Technology and Education (NIPTE) and is currently working to increase the pharmaceutical industry’s understanding of product development and manufacturing. 

Posted 04/27/2017

  Return to Press Releases